South Korea · Delayed Price · Currency is KRW Boditech Med Statistics
Total Valuation
Boditech Med has a market cap or net worth of KRW 210.57 billion. The enterprise value is 189.61 billion.
| Market Cap | 210.57B |
| Enterprise Value | 189.61B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
Boditech Med has 21.71 million shares outstanding. The number of shares has decreased by -0.97% in one year.
| Current Share Class | 21.71M |
| Shares Outstanding | 21.71M |
| Shares Change (YoY) | -0.97% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 33.71% |
| Owned by Institutions (%) | 0.86% |
| Float | 14.01M |
Valuation Ratios
The trailing PE ratio is 8.08.
| PE Ratio | 8.08 |
| Forward PE | n/a |
| PS Ratio | 1.20 |
| PB Ratio | 0.81 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.21 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 7.31 |
| EV / Sales | 1.08 |
| EV / EBITDA | 5.31 |
| EV / EBIT | 7.40 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.46 |
| Quick Ratio | 3.54 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | -0.86 |
| Interest Coverage | 47.66 |
Financial Efficiency
Return on equity (ROE) is 10.63% and return on invested capital (ROIC) is 10.12%.
| Return on Equity (ROE) | 10.63% |
| Return on Assets (ROA) | 5.97% |
| Return on Invested Capital (ROIC) | 10.12% |
| Return on Capital Employed (ROCE) | 9.83% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | 323.06M |
| Profits Per Employee | 47.97M |
| Employee Count | 541 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.63 |
Taxes
In the past 12 months, Boditech Med has paid 5.66 billion in taxes.
| Income Tax | 5.66B |
| Effective Tax Rate | 17.69% |
Stock Price Statistics
The stock price has decreased by -31.00% in the last 52 weeks. The beta is 0.35, so Boditech Med's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -31.00% |
| 50-Day Moving Average | 10,298.80 |
| 200-Day Moving Average | 11,503.20 |
| Relative Strength Index (RSI) | 49.11 |
| Average Volume (20 Days) | 26,149 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Boditech Med had revenue of KRW 174.78 billion and earned 25.95 billion in profits. Earnings per share was 1,199.82.
| Revenue | 174.78B |
| Gross Profit | 101.95B |
| Operating Income | 26.97B |
| Pretax Income | 31.97B |
| Net Income | 25.95B |
| EBITDA | 37.02B |
| EBIT | 26.97B |
| Earnings Per Share (EPS) | 1,199.82 |
Balance Sheet
The company has 52.91 billion in cash and 17.76 billion in debt, with a net cash position of 35.15 billion or 1,619.22 per share.
| Cash & Cash Equivalents | 52.91B |
| Total Debt | 17.76B |
| Net Cash | 35.15B |
| Net Cash Per Share | 1,619.22 |
| Equity (Book Value) | 261.45B |
| Book Value Per Share | 11,390.01 |
| Working Capital | 129.83B |
Cash Flow
In the last 12 months, operating cash flow was 14.82 billion and capital expenditures -35.40 billion, giving a free cash flow of -20.58 billion.
| Operating Cash Flow | 14.82B |
| Capital Expenditures | -35.40B |
| Depreciation & Amortization | 10.04B |
| Net Borrowing | 9.09B |
| Free Cash Flow | -20.58B |
| FCF Per Share | -948.02 |
Margins
Gross margin is 58.33%, with operating and profit margins of 15.43% and 14.85%.
| Gross Margin | 58.33% |
| Operating Margin | 15.43% |
| Pretax Margin | 18.29% |
| Profit Margin | 14.85% |
| EBITDA Margin | 21.18% |
| EBIT Margin | 15.43% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.54%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 1.54% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 12.55% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.97% |
| Shareholder Yield | 2.53% |
| Earnings Yield | 12.32% |
| FCF Yield | -9.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 5, 2017 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Boditech Med has an Altman Z-Score of 6.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.25 |
| Piotroski F-Score | 5 |